Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N05AG01
CAS registry number (Chemical Abstracts Service)
0001841-19-6
Chemical Formula
C29-H31-F2-N3-O
Molecular Weight
475
Therapeutic Category
Neuroleptic
Chemical Name
1,3,8-Triazaspiro[4.5]decan-4-one, 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-
Foreign Names
- Fluspirilenum (Latin)
- Fluspirilen (German)
- Fluspirilène (French)
- Fluspirileno (Spanish)
Generic Names
- Fluspirilene (OS: USAN, BAN)
- Fluspirilène (OS: DCF)
- McN-IR-6218 (IS)
- R 6218 (IS: Janssen)
- Spirodiflamine (IS)
- Fluspirilene (PH: BP 2010, Ph. Eur. 6)
- Fluspirilenum (PH: Ph. Eur. 6)
Brand Names
- Fluspi
Hexal, Germany - Fluspirilen beta
Betapharm, Germany - Fluspirilen Lindo
Lindopharm, Germany - Imap
Abic, Israel; Janssen, Argentina; Janssen, Belgium; Janssen, Cyprus; Janssen, Germany; Janssen, Lebanon; Janssen, Luxembourg; Janssen, Netherlands; Janssen, Saudi Arabia; Janssen, Sudan; Janssen, Yemen; Janssen-Cilag, United Arab Emirates; Janssen-Cilag, Egypt; Janssen-Cilag, Jordan
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment